Home Dermatology PDF: Update on Drugs & Devices: January-February 2022
- You cannot add another "PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea" to your cart. View cart
PDF: Update on Drugs & Devices: January-February 2022
$1.99
PDF Download: Drug update covering: Adalimumab-adbm for SC use – Cyltezo®, Tralokinumab for SC use – Adtralza® (in Canada), Tralokinumab-ldrm for SC use – Adbry™ (in US), Melanoma vaccine for IV use – BNT111, Adalimumab-aqvh for SC use – Yusimry™, and more…